Skip to content
10-Q

Quarterly Report

Peak Bio, Inc.

0000950170-24-077018

← back to feed
Filed
Jun 25, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Jun 21, 2024 23.12M sh
Capex Q3 2023 · Sep 30, 2023 $0
Capex Q3 2023 · Sep 30, 2022 $128.45K
Current Liabilities Q3 2023 · Sep 30, 2023 $18.71M
Current Liabilities Q3 2023 · Dec 31, 2022 $10.8M
Total Liabilities Q3 2023 · Sep 30, 2023 $19.07M
Total Liabilities Q3 2023 · Dec 31, 2022 $15.62M
Current Assets Q3 2023 · Sep 30, 2023 $1.26M
Current Assets Q3 2023 · Dec 31, 2022 $3.23M
Total Assets Q3 2023 · Sep 30, 2023 $1.51M
Total Assets Q3 2023 · Dec 31, 2022 $7.53M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $654.89K
Cash And Equivalents restated Q3 2023 · Sep 30, 2022 $437.4K
Shares Diluted restated Q3 2023 · Sep 30, 2022 17.16M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 17.2M sh
Operating Cash Flow restated Q3 2023 · Sep 30, 2022 −$3.79M
Stockholders Equity restated Q3 2023 · Sep 30, 2022 −$5.46M
Stockholders Equity restated Q3 2023 · Jun 30, 2022 −$3.94M
Stockholders Equity restated Q3 2023 · Mar 31, 2022 −$2.7M
Stockholders Equity restated Q3 2023 · Dec 31, 2021 −$1.94M
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$0.10
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$0.37
Eps Basic restated Q3 2023 · Sep 30, 2022 −$0.10
Eps Basic restated Q3 2023 · Sep 30, 2022 −$0.37
Sga Expense Q3 2023 · Sep 30, 2022 $1.01M
Sga Expense Q3 2023 · Sep 30, 2022 $3.54M
Rd Expense Q3 2023 · Sep 30, 2022 $868.41K
Rd Expense Q3 2023 · Sep 30, 2022 $3.44M
Net Income restated Q3 2023 · Sep 30, 2022 −$1.71M
Net Income restated Q3 2023 · Sep 30, 2022 −$6.34M
Operating Income restated Q3 2023 · Sep 30, 2022 −$1.69M
Operating Income restated Q3 2023 · Sep 30, 2022 −$6.64M
Revenue Q3 2023 · Sep 30, 2022 $192.55K
Revenue Q3 2023 · Sep 30, 2022 $346.41K